Lisa Richardson, MD, MPH, director of the Centers for Disease Control and Prevention’s (CDC’s) Division of Cancer Prevention and Control, joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss CDC’s initiatives for cancer prevention and screening during the COVID-19 coronavirus and flu season. The conversation also covers how oncology nurses can help improve declining screening rates and access a new database of cancer incidence and biomarkers. The advertising messages in this episode are sponsored by Coherus BioSciences.
Check out these resources from today’s episode:
The National Comprehensive Cancer Network (NCCN) makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Hematopoietic Growth Factors. V.2.2020. © National Comprehensive Cancer Network, Inc., 2020. All rights reserved. Accessed July 10, 2020. To view the most recent and complete version of the guideline, go online to NCCN.org.
Expand your knowledge by listening to the Oncology Nursing Podcast.View All Podcasts